Otherwise, Lou Musaang wouldn't have been just a step away from a breakthrough for so many years.
"After all, it's a drug that can treat primary cancer. It was never going to be that easy."
After this incident was over, Xu Kunlin still planned to recall Sorafenib for further experiments. Only a perfect launch of this new drug would bring him the true sense of accomplishment and fame he craved.
Unlike a pure businessman like Xie Bin, Xu Kunlin still had some scientific ambitions.
'I hope the day Jin Pharmaceutical Group goes bankrupt comes soon.'
Xu Kunlin had already made up his mind. After acquiring Jin Pharmaceutical Group, he could also acquire Lou Musaang's team and the team of that young upstart, Wu Ting.
He would have them continue their research and develop new drugs under his command.
...
...
「City First Hospital, Department of Hepatic Tumor Surgery.」
As a newly established department, it only had two outpatient clinics so far.
